ABG
TRAW icon

Ally Bridge Group’s Traws Pharma TRAW Stock Holding History

Ally Bridge Group’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$663K Buy
+786,236
New +$1.08M 0.59% 25

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

Ally Bridge Group's TRAW Position: Q2 2026 in Review

Ally Bridge Group opened a new position in Traws Pharma (TRAW) in Q2 2026: 786,236 shares worth $663K. The stake represents 0.59% of the portfolio and ranks #25 among its holdings.

30 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Ally Bridge Group held 786,236 shares of Traws Pharma worth $663K as of Q2 2026.
  • Traws Pharma was a new Ally Bridge Group position in Q2 2026.
  • Traws Pharma made up 0.59% of Ally Bridge Group's portfolio in Q2 2026, its #25 holding.
  • 30 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Ally Bridge Group's 13F filing for Q2 2026, filed 14 Aug 2026.